Corvus enters $40M ATM equity offering with Jefferies LLC

Corvus Pharmaceuticals, Inc.

Sales agreement for up to $40M in common stock, Jefferies as sales agent.
Jefferies receives up to 3% commission on gross proceeds from sales.
Sales may occur through Nasdaq, block trades, or privately negotiated transactions.
Company may suspend or terminate the agreement at any time; no obligation to sell shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.